From 140 Million Cells to Human Trials: Applying AI & Human Tissue Biology to Accelerate Dermatology Drug Discovery
- Building proprietary cellular atlases through advanced multi-omics approaches to reveal novel disease mechanisms and therapeutic opportunities
- Leveraging AI and machine learning to identify, prioritize and validate targets emerging from complex human biology datasets
- Sharing lessons from advancing an AI-discovered therapeutic from target identification to clinical studies in approximately half the traditional development timeline